Home » Topics » Deals and M&A » Collaboration

Collaboration
RSS

NGM signs agreement with Janssen for novel therapeutics for diabetes

Jan. 4, 2013

Microbiotix enters licensing agreement for MBX-700 and MBX-701

Jan. 4, 2013

Chroma receives milestone payment from GSK for HDAC inhibitor

Jan. 4, 2013

Alize Pharma launches collaborative research program for AZP-531

Jan. 4, 2013

Third milestone in Vernalis' drug discovery collaboration with Lundbeck

Jan. 2, 2013

Evotec and Apeiron Biologics establish cancer immunotherapy collaboration

Jan. 2, 2013

Japanese group enters agreement for new anticancer compounds

Dec. 31, 2012

Johns Hopkins receives additional NIH grant for studies of Q-Cells in ALS

Dec. 31, 2012

Ajinomoto Pharmaceuticals and Yoshindo to form joint venture

Dec. 28, 2012

Infinity Pharmaceuticals amends license agreement with Millennium

Dec. 28, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 15, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...